B.O.S.S. Retirement Advisors LLC Acquires New Holdings in Elevance Health, Inc. (NYSE:ELV)

B.O.S.S. Retirement Advisors LLC acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 760 shares of the company’s stock, valued at approximately $280,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ELV. Public Sector Pension Investment Board grew its stake in Elevance Health by 71.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 8,932 shares of the company’s stock worth $4,840,000 after buying an additional 3,711 shares in the last quarter. Fred Alger Management LLC purchased a new position in Elevance Health in the 2nd quarter worth approximately $6,833,000. Daymark Wealth Partners LLC grew its stake in Elevance Health by 3.1% in the 2nd quarter. Daymark Wealth Partners LLC now owns 2,120 shares of the company’s stock worth $1,149,000 after buying an additional 64 shares in the last quarter. MBB Public Markets I LLC purchased a new position in Elevance Health in the 2nd quarter worth approximately $8,987,000. Finally, Mackenzie Financial Corp grew its stake in Elevance Health by 1.1% in the 2nd quarter. Mackenzie Financial Corp now owns 73,964 shares of the company’s stock worth $40,078,000 after buying an additional 773 shares in the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Elevance Health Trading Up 0.0 %

NYSE:ELV opened at $401.43 on Friday. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26. The firm has a market capitalization of $93.10 billion, a P/E ratio of 14.63, a P/E/G ratio of 1.11 and a beta of 0.84. The company has a fifty day moving average of $386.21 and a 200 day moving average of $462.34.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a net margin of 3.68% and a return on equity of 19.56%. On average, research analysts predict that Elevance Health, Inc. will post 32.95 earnings per share for the current year.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a $1.71 dividend. The ex-dividend date of this dividend is Monday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.70%. Elevance Health’s dividend payout ratio is 26.71%.

Wall Street Analyst Weigh In

ELV has been the subject of a number of recent research reports. StockNews.com upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a report on Friday, January 17th. Royal Bank of Canada lowered their price objective on shares of Elevance Health from $585.00 to $478.00 and set an “outperform” rating for the company in a report on Friday, October 18th. Raymond James set a $485.00 price objective on shares of Elevance Health in a report on Friday, October 18th. TD Cowen lowered their price objective on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a report on Monday, October 21st. Finally, Barclays boosted their price objective on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a report on Friday. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $525.60.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.